Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 31Unknown 12Recruiting 6Active not recruiting 5Terminated 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Neoplasms 40Breast Neoplasms 38Prostatic Neoplasms 24Colorectal Neoplasms 23Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 9Brain Neoplasms 9Lung Neoplasms 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Esophageal Neoplasms 7Sarcoma 6Ovarian Neoplasms 6Esophageal Squamous Cell Carcinoma 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Epilepsy 5Dementia 5Cholangiocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Diabetes Mellitus, Type 2 × Clear all
NCT05785780 2026-05-29

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Rutgers, The State University of New Jersey

Phase NA Enrolling by invitation
30 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡